nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2C19—Esomeprazole—Barrett's esophagus	0.178	0.265	CbGbCtD
Eletriptan—CYP2C19—Omeprazole—Barrett's esophagus	0.105	0.156	CbGbCtD
Eletriptan—CYP2C9—Omeprazole—Barrett's esophagus	0.0872	0.13	CbGbCtD
Eletriptan—CYP3A4—Esomeprazole—Barrett's esophagus	0.086	0.128	CbGbCtD
Eletriptan—ABCB1—Omeprazole—Barrett's esophagus	0.0846	0.126	CbGbCtD
Eletriptan—CYP2D6—Omeprazole—Barrett's esophagus	0.0797	0.119	CbGbCtD
Eletriptan—CYP3A4—Omeprazole—Barrett's esophagus	0.0507	0.0756	CbGbCtD
Eletriptan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00262	0.0794	CbGpPWpGaD
Eletriptan—Menstrual disorder—Esomeprazole—Barrett's esophagus	0.00254	0.00857	CcSEcCtD
Eletriptan—Menstrual disorder—Omeprazole—Barrett's esophagus	0.00254	0.00857	CcSEcCtD
Eletriptan—Apathy—Esomeprazole—Barrett's esophagus	0.00242	0.00818	CcSEcCtD
Eletriptan—Apathy—Omeprazole—Barrett's esophagus	0.00242	0.00818	CcSEcCtD
Eletriptan—Flat affect—Omeprazole—Barrett's esophagus	0.0024	0.00811	CcSEcCtD
Eletriptan—Flat affect—Esomeprazole—Barrett's esophagus	0.0024	0.00811	CcSEcCtD
Eletriptan—Tongue disorder—Esomeprazole—Barrett's esophagus	0.00238	0.00803	CcSEcCtD
Eletriptan—Tongue disorder—Omeprazole—Barrett's esophagus	0.00238	0.00803	CcSEcCtD
Eletriptan—Otitis media—Esomeprazole—Barrett's esophagus	0.00222	0.0075	CcSEcCtD
Eletriptan—Otitis media—Omeprazole—Barrett's esophagus	0.00222	0.0075	CcSEcCtD
Eletriptan—Accidental injury—Esomeprazole—Barrett's esophagus	0.00196	0.0066	CcSEcCtD
Eletriptan—Accidental injury—Omeprazole—Barrett's esophagus	0.00196	0.0066	CcSEcCtD
Eletriptan—Arthropathy—Omeprazole—Barrett's esophagus	0.0019	0.00642	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.0019	0.00642	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.0019	0.00642	CcSEcCtD
Eletriptan—Arthropathy—Esomeprazole—Barrett's esophagus	0.0019	0.00642	CcSEcCtD
Eletriptan—Glossitis—Esomeprazole—Barrett's esophagus	0.00188	0.00634	CcSEcCtD
Eletriptan—Glossitis—Omeprazole—Barrett's esophagus	0.00188	0.00634	CcSEcCtD
Eletriptan—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Hiccups—Esomeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Hiccups—Omeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00173	0.00584	CcSEcCtD
Eletriptan—PTGS1—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.0017	0.0516	CbGpPWpGaD
Eletriptan—Eructation—Esomeprazole—Barrett's esophagus	0.0017	0.00574	CcSEcCtD
Eletriptan—Eructation—Omeprazole—Barrett's esophagus	0.0017	0.00574	CcSEcCtD
Eletriptan—Candida infection—Esomeprazole—Barrett's esophagus	0.00165	0.00558	CcSEcCtD
Eletriptan—Candida infection—Omeprazole—Barrett's esophagus	0.00165	0.00558	CcSEcCtD
Eletriptan—Vaginal infection—Omeprazole—Barrett's esophagus	0.00163	0.00552	CcSEcCtD
Eletriptan—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00163	0.00552	CcSEcCtD
Eletriptan—Dry eye—Esomeprazole—Barrett's esophagus	0.0016	0.0054	CcSEcCtD
Eletriptan—Dry eye—Omeprazole—Barrett's esophagus	0.0016	0.0054	CcSEcCtD
Eletriptan—Oesophagitis—Omeprazole—Barrett's esophagus	0.00158	0.00534	CcSEcCtD
Eletriptan—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00158	0.00534	CcSEcCtD
Eletriptan—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00157	0.00531	CcSEcCtD
Eletriptan—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00157	0.00531	CcSEcCtD
Eletriptan—Urine output increased—Omeprazole—Barrett's esophagus	0.00156	0.00528	CcSEcCtD
Eletriptan—Urine output increased—Esomeprazole—Barrett's esophagus	0.00156	0.00528	CcSEcCtD
Eletriptan—Hypertonia—Omeprazole—Barrett's esophagus	0.00152	0.00512	CcSEcCtD
Eletriptan—Hypertonia—Esomeprazole—Barrett's esophagus	0.00152	0.00512	CcSEcCtD
Eletriptan—Abnormal vision—Omeprazole—Barrett's esophagus	0.00151	0.0051	CcSEcCtD
Eletriptan—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00151	0.0051	CcSEcCtD
Eletriptan—Ear pain—Omeprazole—Barrett's esophagus	0.00147	0.00497	CcSEcCtD
Eletriptan—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00147	0.00497	CcSEcCtD
Eletriptan—Ear pain—Esomeprazole—Barrett's esophagus	0.00147	0.00497	CcSEcCtD
Eletriptan—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00147	0.00497	CcSEcCtD
Eletriptan—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00145	0.0049	CcSEcCtD
Eletriptan—Sleep disorder—Omeprazole—Barrett's esophagus	0.00145	0.0049	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00144	0.00488	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00144	0.00488	CcSEcCtD
Eletriptan—Polyuria—Esomeprazole—Barrett's esophagus	0.00143	0.00483	CcSEcCtD
Eletriptan—Polyuria—Omeprazole—Barrett's esophagus	0.00143	0.00483	CcSEcCtD
Eletriptan—Vascular purpura—Esomeprazole—Barrett's esophagus	0.0014	0.00474	CcSEcCtD
Eletriptan—Vascular purpura—Omeprazole—Barrett's esophagus	0.0014	0.00474	CcSEcCtD
Eletriptan—Injury—Esomeprazole—Barrett's esophagus	0.00137	0.00461	CcSEcCtD
Eletriptan—Injury—Omeprazole—Barrett's esophagus	0.00137	0.00461	CcSEcCtD
Eletriptan—Increased appetite—Omeprazole—Barrett's esophagus	0.00134	0.00451	CcSEcCtD
Eletriptan—Increased appetite—Esomeprazole—Barrett's esophagus	0.00134	0.00451	CcSEcCtD
Eletriptan—Thirst—Esomeprazole—Barrett's esophagus	0.00132	0.00446	CcSEcCtD
Eletriptan—Thirst—Omeprazole—Barrett's esophagus	0.00132	0.00446	CcSEcCtD
Eletriptan—Purpura—Esomeprazole—Barrett's esophagus	0.0013	0.0044	CcSEcCtD
Eletriptan—Purpura—Omeprazole—Barrett's esophagus	0.0013	0.0044	CcSEcCtD
Eletriptan—Arthritis—Esomeprazole—Barrett's esophagus	0.00129	0.00436	CcSEcCtD
Eletriptan—Arthritis—Omeprazole—Barrett's esophagus	0.00129	0.00436	CcSEcCtD
Eletriptan—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00126	0.00424	CcSEcCtD
Eletriptan—Diplopia—Esomeprazole—Barrett's esophagus	0.00126	0.00424	CcSEcCtD
Eletriptan—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00126	0.00424	CcSEcCtD
Eletriptan—Diplopia—Omeprazole—Barrett's esophagus	0.00126	0.00424	CcSEcCtD
Eletriptan—Migraine—Esomeprazole—Barrett's esophagus	0.00124	0.00417	CcSEcCtD
Eletriptan—Migraine—Omeprazole—Barrett's esophagus	0.00124	0.00417	CcSEcCtD
Eletriptan—Face oedema—Omeprazole—Barrett's esophagus	0.00121	0.00409	CcSEcCtD
Eletriptan—Face oedema—Esomeprazole—Barrett's esophagus	0.00121	0.00409	CcSEcCtD
Eletriptan—Dry skin—Omeprazole—Barrett's esophagus	0.00115	0.00389	CcSEcCtD
Eletriptan—Dry skin—Esomeprazole—Barrett's esophagus	0.00115	0.00389	CcSEcCtD
Eletriptan—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00115	0.00387	CcSEcCtD
Eletriptan—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00115	0.00387	CcSEcCtD
Eletriptan—Cramp muscle—Omeprazole—Barrett's esophagus	0.00113	0.00382	CcSEcCtD
Eletriptan—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00113	0.00382	CcSEcCtD
Eletriptan—Gastritis—Esomeprazole—Barrett's esophagus	0.00111	0.00375	CcSEcCtD
Eletriptan—Gastritis—Omeprazole—Barrett's esophagus	0.00111	0.00375	CcSEcCtD
Eletriptan—Muscular weakness—Omeprazole—Barrett's esophagus	0.00111	0.00374	CcSEcCtD
Eletriptan—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00111	0.00374	CcSEcCtD
Eletriptan—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00109	0.00369	CcSEcCtD
Eletriptan—Abdominal distension—Omeprazole—Barrett's esophagus	0.00109	0.00369	CcSEcCtD
Eletriptan—Asthma—Esomeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Influenza—Esomeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Dysphagia—Esomeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Asthma—Omeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Influenza—Omeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Dysphagia—Omeprazole—Barrett's esophagus	0.00109	0.00367	CcSEcCtD
Eletriptan—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00106	0.00357	CcSEcCtD
Eletriptan—Angina pectoris—Omeprazole—Barrett's esophagus	0.00106	0.00357	CcSEcCtD
Eletriptan—Pollakiuria—Omeprazole—Barrett's esophagus	0.001	0.00339	CcSEcCtD
Eletriptan—Pollakiuria—Esomeprazole—Barrett's esophagus	0.001	0.00339	CcSEcCtD
Eletriptan—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.001	0.00338	CcSEcCtD
Eletriptan—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.001	0.00338	CcSEcCtD
Eletriptan—Weight increased—Omeprazole—Barrett's esophagus	0.000988	0.00334	CcSEcCtD
Eletriptan—Weight increased—Esomeprazole—Barrett's esophagus	0.000988	0.00334	CcSEcCtD
Eletriptan—Weight decreased—Omeprazole—Barrett's esophagus	0.000982	0.00332	CcSEcCtD
Eletriptan—Weight decreased—Esomeprazole—Barrett's esophagus	0.000982	0.00332	CcSEcCtD
Eletriptan—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000956	0.029	CbGpPWpGaD
Eletriptan—PTGS1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000946	0.0287	CbGpPWpGaD
Eletriptan—Stomatitis—Esomeprazole—Barrett's esophagus	0.000943	0.00319	CcSEcCtD
Eletriptan—Stomatitis—Omeprazole—Barrett's esophagus	0.000943	0.00319	CcSEcCtD
Eletriptan—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000941	0.00318	CcSEcCtD
Eletriptan—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000941	0.00318	CcSEcCtD
Eletriptan—Epistaxis—Esomeprazole—Barrett's esophagus	0.000913	0.00308	CcSEcCtD
Eletriptan—Epistaxis—Omeprazole—Barrett's esophagus	0.000913	0.00308	CcSEcCtD
Eletriptan—Sinusitis—Omeprazole—Barrett's esophagus	0.000908	0.00307	CcSEcCtD
Eletriptan—Sinusitis—Esomeprazole—Barrett's esophagus	0.000908	0.00307	CcSEcCtD
Eletriptan—Bradycardia—Esomeprazole—Barrett's esophagus	0.000884	0.00299	CcSEcCtD
Eletriptan—Bradycardia—Omeprazole—Barrett's esophagus	0.000884	0.00299	CcSEcCtD
Eletriptan—Rhinitis—Omeprazole—Barrett's esophagus	0.000871	0.00294	CcSEcCtD
Eletriptan—Rhinitis—Esomeprazole—Barrett's esophagus	0.000871	0.00294	CcSEcCtD
Eletriptan—Hallucination—Omeprazole—Barrett's esophagus	0.000864	0.00292	CcSEcCtD
Eletriptan—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000864	0.00292	CcSEcCtD
Eletriptan—Hallucination—Esomeprazole—Barrett's esophagus	0.000864	0.00292	CcSEcCtD
Eletriptan—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000864	0.00292	CcSEcCtD
Eletriptan—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000862	0.00291	CcSEcCtD
Eletriptan—Pharyngitis—Omeprazole—Barrett's esophagus	0.000862	0.00291	CcSEcCtD
Eletriptan—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000858	0.0029	CcSEcCtD
Eletriptan—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000858	0.0029	CcSEcCtD
Eletriptan—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000856	0.00289	CcSEcCtD
Eletriptan—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000856	0.00289	CcSEcCtD
Eletriptan—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000852	0.00288	CcSEcCtD
Eletriptan—Urethral disorder—Omeprazole—Barrett's esophagus	0.000852	0.00288	CcSEcCtD
Eletriptan—Visual impairment—Omeprazole—Barrett's esophagus	0.000837	0.00283	CcSEcCtD
Eletriptan—Visual impairment—Esomeprazole—Barrett's esophagus	0.000837	0.00283	CcSEcCtD
Eletriptan—Tinnitus—Omeprazole—Barrett's esophagus	0.00081	0.00274	CcSEcCtD
Eletriptan—Tinnitus—Esomeprazole—Barrett's esophagus	0.00081	0.00274	CcSEcCtD
Eletriptan—Flushing—Esomeprazole—Barrett's esophagus	0.000806	0.00272	CcSEcCtD
Eletriptan—Flushing—Omeprazole—Barrett's esophagus	0.000806	0.00272	CcSEcCtD
Eletriptan—Immune system disorder—Omeprazole—Barrett's esophagus	0.000785	0.00265	CcSEcCtD
Eletriptan—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000785	0.00265	CcSEcCtD
Eletriptan—Chills—Omeprazole—Barrett's esophagus	0.00078	0.00263	CcSEcCtD
Eletriptan—Chills—Esomeprazole—Barrett's esophagus	0.00078	0.00263	CcSEcCtD
Eletriptan—Alopecia—Esomeprazole—Barrett's esophagus	0.000768	0.00259	CcSEcCtD
Eletriptan—Alopecia—Omeprazole—Barrett's esophagus	0.000768	0.00259	CcSEcCtD
Eletriptan—Flatulence—Omeprazole—Barrett's esophagus	0.000745	0.00252	CcSEcCtD
Eletriptan—Flatulence—Esomeprazole—Barrett's esophagus	0.000745	0.00252	CcSEcCtD
Eletriptan—Tension—Esomeprazole—Barrett's esophagus	0.000742	0.00251	CcSEcCtD
Eletriptan—Tension—Omeprazole—Barrett's esophagus	0.000742	0.00251	CcSEcCtD
Eletriptan—Dysgeusia—Omeprazole—Barrett's esophagus	0.000741	0.0025	CcSEcCtD
Eletriptan—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000741	0.0025	CcSEcCtD
Eletriptan—Nervousness—Esomeprazole—Barrett's esophagus	0.000735	0.00248	CcSEcCtD
Eletriptan—Nervousness—Omeprazole—Barrett's esophagus	0.000735	0.00248	CcSEcCtD
Eletriptan—Back pain—Esomeprazole—Barrett's esophagus	0.000732	0.00247	CcSEcCtD
Eletriptan—Back pain—Omeprazole—Barrett's esophagus	0.000732	0.00247	CcSEcCtD
Eletriptan—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000727	0.00246	CcSEcCtD
Eletriptan—Muscle spasms—Omeprazole—Barrett's esophagus	0.000727	0.00246	CcSEcCtD
Eletriptan—Tremor—Esomeprazole—Barrett's esophagus	0.000709	0.00239	CcSEcCtD
Eletriptan—Tremor—Omeprazole—Barrett's esophagus	0.000709	0.00239	CcSEcCtD
Eletriptan—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000702	0.00237	CcSEcCtD
Eletriptan—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000702	0.00237	CcSEcCtD
Eletriptan—Anaemia—Esomeprazole—Barrett's esophagus	0.000699	0.00236	CcSEcCtD
Eletriptan—Anaemia—Omeprazole—Barrett's esophagus	0.000699	0.00236	CcSEcCtD
Eletriptan—Agitation—Esomeprazole—Barrett's esophagus	0.000695	0.00235	CcSEcCtD
Eletriptan—Agitation—Omeprazole—Barrett's esophagus	0.000695	0.00235	CcSEcCtD
Eletriptan—Angioedema—Omeprazole—Barrett's esophagus	0.000691	0.00233	CcSEcCtD
Eletriptan—Angioedema—Esomeprazole—Barrett's esophagus	0.000691	0.00233	CcSEcCtD
Eletriptan—Malaise—Esomeprazole—Barrett's esophagus	0.000682	0.0023	CcSEcCtD
Eletriptan—Malaise—Omeprazole—Barrett's esophagus	0.000682	0.0023	CcSEcCtD
Eletriptan—Vertigo—Omeprazole—Barrett's esophagus	0.000679	0.00229	CcSEcCtD
Eletriptan—Vertigo—Esomeprazole—Barrett's esophagus	0.000679	0.00229	CcSEcCtD
Eletriptan—Leukopenia—Esomeprazole—Barrett's esophagus	0.000677	0.00229	CcSEcCtD
Eletriptan—Leukopenia—Omeprazole—Barrett's esophagus	0.000677	0.00229	CcSEcCtD
Eletriptan—Palpitations—Esomeprazole—Barrett's esophagus	0.000668	0.00226	CcSEcCtD
Eletriptan—Palpitations—Omeprazole—Barrett's esophagus	0.000668	0.00226	CcSEcCtD
Eletriptan—Cough—Omeprazole—Barrett's esophagus	0.00066	0.00223	CcSEcCtD
Eletriptan—Cough—Esomeprazole—Barrett's esophagus	0.00066	0.00223	CcSEcCtD
Eletriptan—Hypertension—Omeprazole—Barrett's esophagus	0.000653	0.00221	CcSEcCtD
Eletriptan—Hypertension—Esomeprazole—Barrett's esophagus	0.000653	0.00221	CcSEcCtD
Eletriptan—Arthralgia—Esomeprazole—Barrett's esophagus	0.000644	0.00217	CcSEcCtD
Eletriptan—Myalgia—Esomeprazole—Barrett's esophagus	0.000644	0.00217	CcSEcCtD
Eletriptan—Myalgia—Omeprazole—Barrett's esophagus	0.000644	0.00217	CcSEcCtD
Eletriptan—Arthralgia—Omeprazole—Barrett's esophagus	0.000644	0.00217	CcSEcCtD
Eletriptan—Anxiety—Omeprazole—Barrett's esophagus	0.000642	0.00217	CcSEcCtD
Eletriptan—Anxiety—Esomeprazole—Barrett's esophagus	0.000642	0.00217	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000639	0.00216	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000639	0.00216	CcSEcCtD
Eletriptan—Discomfort—Omeprazole—Barrett's esophagus	0.000636	0.00215	CcSEcCtD
Eletriptan—Discomfort—Esomeprazole—Barrett's esophagus	0.000636	0.00215	CcSEcCtD
Eletriptan—Dry mouth—Omeprazole—Barrett's esophagus	0.00063	0.00213	CcSEcCtD
Eletriptan—Dry mouth—Esomeprazole—Barrett's esophagus	0.00063	0.00213	CcSEcCtD
Eletriptan—Confusional state—Esomeprazole—Barrett's esophagus	0.000622	0.0021	CcSEcCtD
Eletriptan—Confusional state—Omeprazole—Barrett's esophagus	0.000622	0.0021	CcSEcCtD
Eletriptan—Shock—Omeprazole—Barrett's esophagus	0.000607	0.00205	CcSEcCtD
Eletriptan—Shock—Esomeprazole—Barrett's esophagus	0.000607	0.00205	CcSEcCtD
Eletriptan—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000605	0.00204	CcSEcCtD
Eletriptan—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000605	0.00204	CcSEcCtD
Eletriptan—Tachycardia—Esomeprazole—Barrett's esophagus	0.000602	0.00203	CcSEcCtD
Eletriptan—Tachycardia—Omeprazole—Barrett's esophagus	0.000602	0.00203	CcSEcCtD
Eletriptan—Skin disorder—Omeprazole—Barrett's esophagus	0.0006	0.00202	CcSEcCtD
Eletriptan—Skin disorder—Esomeprazole—Barrett's esophagus	0.0006	0.00202	CcSEcCtD
Eletriptan—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000597	0.00202	CcSEcCtD
Eletriptan—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000597	0.00202	CcSEcCtD
Eletriptan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000589	0.0179	CbGpPWpGaD
Eletriptan—Anorexia—Omeprazole—Barrett's esophagus	0.000588	0.00199	CcSEcCtD
Eletriptan—Anorexia—Esomeprazole—Barrett's esophagus	0.000588	0.00199	CcSEcCtD
Eletriptan—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000586	0.0178	CbGpPWpGaD
Eletriptan—CYP2A6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000578	0.0175	CbGpPWpGaD
Eletriptan—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000562	0.0019	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000562	0.0019	CcSEcCtD
Eletriptan—Insomnia—Omeprazole—Barrett's esophagus	0.000558	0.00189	CcSEcCtD
Eletriptan—Insomnia—Esomeprazole—Barrett's esophagus	0.000558	0.00189	CcSEcCtD
Eletriptan—Paraesthesia—Omeprazole—Barrett's esophagus	0.000554	0.00187	CcSEcCtD
Eletriptan—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000554	0.00187	CcSEcCtD
Eletriptan—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00055	0.00186	CcSEcCtD
Eletriptan—Dyspnoea—Omeprazole—Barrett's esophagus	0.00055	0.00186	CcSEcCtD
Eletriptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000549	0.0166	CbGpPWpGaD
Eletriptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000549	0.0166	CbGpPWpGaD
Eletriptan—Somnolence—Esomeprazole—Barrett's esophagus	0.000549	0.00185	CcSEcCtD
Eletriptan—Somnolence—Omeprazole—Barrett's esophagus	0.000549	0.00185	CcSEcCtD
Eletriptan—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000546	0.0165	CbGpPWpGaD
Eletriptan—Dyspepsia—Omeprazole—Barrett's esophagus	0.000543	0.00183	CcSEcCtD
Eletriptan—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000543	0.00183	CcSEcCtD
Eletriptan—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000537	0.00181	CcSEcCtD
Eletriptan—Decreased appetite—Omeprazole—Barrett's esophagus	0.000537	0.00181	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000533	0.0018	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000533	0.0018	CcSEcCtD
Eletriptan—Fatigue—Esomeprazole—Barrett's esophagus	0.000532	0.0018	CcSEcCtD
Eletriptan—Fatigue—Omeprazole—Barrett's esophagus	0.000532	0.0018	CcSEcCtD
Eletriptan—Constipation—Omeprazole—Barrett's esophagus	0.000528	0.00178	CcSEcCtD
Eletriptan—Pain—Omeprazole—Barrett's esophagus	0.000528	0.00178	CcSEcCtD
Eletriptan—Constipation—Esomeprazole—Barrett's esophagus	0.000528	0.00178	CcSEcCtD
Eletriptan—Pain—Esomeprazole—Barrett's esophagus	0.000528	0.00178	CcSEcCtD
Eletriptan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.000514	0.0156	CbGpPWpGaD
Eletriptan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000513	0.0155	CbGpPWpGaD
Eletriptan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000513	0.0155	CbGpPWpGaD
Eletriptan—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000509	0.00172	CcSEcCtD
Eletriptan—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000509	0.00172	CcSEcCtD
Eletriptan—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000505	0.0017	CcSEcCtD
Eletriptan—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000505	0.0017	CcSEcCtD
Eletriptan—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000502	0.0152	CbGpPWpGaD
Eletriptan—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000497	0.0151	CbGpPWpGaD
Eletriptan—Urticaria—Omeprazole—Barrett's esophagus	0.00049	0.00166	CcSEcCtD
Eletriptan—Urticaria—Esomeprazole—Barrett's esophagus	0.00049	0.00166	CcSEcCtD
Eletriptan—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000488	0.00165	CcSEcCtD
Eletriptan—Abdominal pain—Omeprazole—Barrett's esophagus	0.000488	0.00165	CcSEcCtD
Eletriptan—Body temperature increased—Omeprazole—Barrett's esophagus	0.000488	0.00165	CcSEcCtD
Eletriptan—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000488	0.00165	CcSEcCtD
Eletriptan—CYP2A6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000475	0.0144	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000475	0.0144	CbGpPWpGaD
Eletriptan—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000455	0.00154	CcSEcCtD
Eletriptan—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000455	0.00154	CcSEcCtD
Eletriptan—Asthenia—Esomeprazole—Barrett's esophagus	0.000443	0.0015	CcSEcCtD
Eletriptan—Asthenia—Omeprazole—Barrett's esophagus	0.000443	0.0015	CcSEcCtD
Eletriptan—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000437	0.0132	CbGpPWpGaD
Eletriptan—Pruritus—Esomeprazole—Barrett's esophagus	0.000437	0.00147	CcSEcCtD
Eletriptan—Pruritus—Omeprazole—Barrett's esophagus	0.000437	0.00147	CcSEcCtD
Eletriptan—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000422	0.00143	CcSEcCtD
Eletriptan—Diarrhoea—Omeprazole—Barrett's esophagus	0.000422	0.00143	CcSEcCtD
Eletriptan—Dizziness—Esomeprazole—Barrett's esophagus	0.000408	0.00138	CcSEcCtD
Eletriptan—Dizziness—Omeprazole—Barrett's esophagus	0.000408	0.00138	CcSEcCtD
Eletriptan—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000403	0.0122	CbGpPWpGaD
Eletriptan—Vomiting—Omeprazole—Barrett's esophagus	0.000392	0.00133	CcSEcCtD
Eletriptan—Vomiting—Esomeprazole—Barrett's esophagus	0.000392	0.00133	CcSEcCtD
Eletriptan—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.00039	0.0118	CbGpPWpGaD
Eletriptan—Rash—Omeprazole—Barrett's esophagus	0.000389	0.00131	CcSEcCtD
Eletriptan—Rash—Esomeprazole—Barrett's esophagus	0.000389	0.00131	CcSEcCtD
Eletriptan—Dermatitis—Omeprazole—Barrett's esophagus	0.000389	0.00131	CcSEcCtD
Eletriptan—Dermatitis—Esomeprazole—Barrett's esophagus	0.000389	0.00131	CcSEcCtD
Eletriptan—Headache—Esomeprazole—Barrett's esophagus	0.000387	0.00131	CcSEcCtD
Eletriptan—Headache—Omeprazole—Barrett's esophagus	0.000387	0.00131	CcSEcCtD
Eletriptan—Nausea—Esomeprazole—Barrett's esophagus	0.000367	0.00124	CcSEcCtD
Eletriptan—Nausea—Omeprazole—Barrett's esophagus	0.000367	0.00124	CcSEcCtD
Eletriptan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000357	0.0108	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000353	0.0107	CbGpPWpGaD
Eletriptan—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000353	0.0107	CbGpPWpGaD
Eletriptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000338	0.0103	CbGpPWpGaD
Eletriptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000338	0.0103	CbGpPWpGaD
Eletriptan—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000334	0.0101	CbGpPWpGaD
Eletriptan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000329	0.00996	CbGpPWpGaD
Eletriptan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000326	0.00987	CbGpPWpGaD
Eletriptan—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000324	0.00983	CbGpPWpGaD
Eletriptan—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000322	0.00974	CbGpPWpGaD
Eletriptan—HTR2B—G alpha (q) signalling events—GAST—Barrett's esophagus	0.0003	0.00908	CbGpPWpGaD
Eletriptan—HTR1F—G alpha (i) signalling events—SST—Barrett's esophagus	0.000291	0.00881	CbGpPWpGaD
Eletriptan—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00029	0.00878	CbGpPWpGaD
Eletriptan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000279	0.00846	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—SST—Barrett's esophagus	0.000274	0.00831	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000268	0.00812	CbGpPWpGaD
Eletriptan—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000267	0.00809	CbGpPWpGaD
Eletriptan—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000266	0.00807	CbGpPWpGaD
Eletriptan—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000264	0.008	CbGpPWpGaD
Eletriptan—CYP2A6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000252	0.00765	CbGpPWpGaD
Eletriptan—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000235	0.00711	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000231	0.00701	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000218	0.00661	CbGpPWpGaD
Eletriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000215	0.00651	CbGpPWpGaD
Eletriptan—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000212	0.00642	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000193	0.00583	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—SST—Barrett's esophagus	0.000186	0.00563	CbGpPWpGaD
Eletriptan—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000186	0.00562	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—SST—Barrett's esophagus	0.000182	0.00552	CbGpPWpGaD
Eletriptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000181	0.00548	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—SST—Barrett's esophagus	0.000176	0.00534	CbGpPWpGaD
Eletriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000174	0.00528	CbGpPWpGaD
Eletriptan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000169	0.00512	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—SST—Barrett's esophagus	0.000166	0.00503	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000154	0.00466	CbGpPWpGaD
Eletriptan—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000152	0.0046	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000149	0.00451	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000148	0.00448	CbGpPWpGaD
Eletriptan—CYP2A6—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000146	0.00441	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—GAST—Barrett's esophagus	0.000145	0.0044	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000145	0.00439	CbGpPWpGaD
Eletriptan—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000142	0.00429	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.00014	0.00425	CbGpPWpGaD
Eletriptan—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00014	0.00423	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—SST—Barrett's esophagus	0.000139	0.0042	CbGpPWpGaD
Eletriptan—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000138	0.00419	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—GAST—Barrett's esophagus	0.000137	0.00415	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000136	0.00412	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000135	0.0041	CbGpPWpGaD
Eletriptan—CYP2A6—NRF2 pathway—HGF—Barrett's esophagus	0.000132	0.004	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—GAST—Barrett's esophagus	0.000132	0.00399	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—GAST—Barrett's esophagus	0.000124	0.00377	CbGpPWpGaD
Eletriptan—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000122	0.00368	CbGpPWpGaD
Eletriptan—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000118	0.00358	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—SST—Barrett's esophagus	0.000113	0.00343	CbGpPWpGaD
Eletriptan—HTR1F—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000113	0.00343	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—SST—Barrett's esophagus	0.000113	0.00341	CbGpPWpGaD
Eletriptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000111	0.00337	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00011	0.00334	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—SST—Barrett's esophagus	0.00011	0.00334	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000108	0.00328	CbGpPWpGaD
Eletriptan—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000107	0.00324	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000107	0.00324	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—SST—Barrett's esophagus	0.000104	0.00314	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—SST—Barrett's esophagus	9.95e-05	0.00301	CbGpPWpGaD
Eletriptan—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.76e-05	0.00296	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—SST—Barrett's esophagus	9.39e-05	0.00284	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—GAST—Barrett's esophagus	9.35e-05	0.00283	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—GAST—Barrett's esophagus	9.28e-05	0.00281	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.25e-05	0.0028	CbGpPWpGaD
Eletriptan—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.13e-05	0.00276	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—GAST—Barrett's esophagus	9.09e-05	0.00275	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—SST—Barrett's esophagus	9.04e-05	0.00274	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	9.01e-05	0.00273	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GAST—Barrett's esophagus	8.54e-05	0.00259	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—SST—Barrett's esophagus	8.52e-05	0.00258	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	8.5e-05	0.00257	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GAST—Barrett's esophagus	8.49e-05	0.00257	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GAST—Barrett's esophagus	8.43e-05	0.00255	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—SST—Barrett's esophagus	8.4e-05	0.00254	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GAST—Barrett's esophagus	8.26e-05	0.0025	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.8e-05	0.00236	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GAST—Barrett's esophagus	7.79e-05	0.00236	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GAST—Barrett's esophagus	7.76e-05	0.00235	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	7.5e-05	0.00227	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GAST—Barrett's esophagus	7.35e-05	0.00223	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.25e-05	0.0022	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.11e-05	0.00215	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.09e-05	0.00215	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.03e-05	0.00213	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GAST—Barrett's esophagus	6.93e-05	0.0021	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—CXCL8—Barrett's esophagus	6.86e-05	0.00208	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—CXCL8—Barrett's esophagus	6.47e-05	0.00196	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.45e-05	0.00195	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—SST—Barrett's esophagus	6.41e-05	0.00194	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—SST—Barrett's esophagus	6.36e-05	0.00193	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GAST—Barrett's esophagus	6.29e-05	0.00191	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—SST—Barrett's esophagus	6.23e-05	0.00189	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGES—Barrett's esophagus	6.02e-05	0.00182	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—SST—Barrett's esophagus	5.85e-05	0.00177	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—SST—Barrett's esophagus	5.82e-05	0.00176	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.8e-05	0.00176	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—SST—Barrett's esophagus	5.78e-05	0.00175	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.76e-05	0.00175	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGES—Barrett's esophagus	5.69e-05	0.00173	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—SST—Barrett's esophagus	5.66e-05	0.00171	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.64e-05	0.00171	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.4e-05	0.00164	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SST—Barrett's esophagus	5.34e-05	0.00162	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—SST—Barrett's esophagus	5.32e-05	0.00161	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.3e-05	0.00161	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—Barrett's esophagus	5.07e-05	0.00154	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SST—Barrett's esophagus	5.04e-05	0.00153	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GAST—Barrett's esophagus	5.01e-05	0.00152	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GAST—Barrett's esophagus	4.98e-05	0.00151	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GAST—Barrett's esophagus	4.88e-05	0.00148	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—SST—Barrett's esophagus	4.75e-05	0.00144	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.71e-05	0.00143	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GAST—Barrett's esophagus	4.58e-05	0.00139	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	4.56e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—CXCL8—Barrett's esophagus	4.42e-05	0.00134	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—CXCL8—Barrett's esophagus	4.39e-05	0.00133	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP26A1—Barrett's esophagus	4.32e-05	0.00131	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SST—Barrett's esophagus	4.31e-05	0.00131	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.3e-05	0.0013	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—CXCL8—Barrett's esophagus	4.3e-05	0.0013	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—CXCL8—Barrett's esophagus	4.04e-05	0.00122	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.95e-05	0.0012	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.88e-05	0.00117	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GAST—Barrett's esophagus	3.72e-05	0.00113	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.66e-05	0.00111	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.57e-05	0.00108	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CXCL8—Barrett's esophagus	3.52e-05	0.00107	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.47e-05	0.00105	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SST—Barrett's esophagus	3.44e-05	0.00104	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SST—Barrett's esophagus	3.41e-05	0.00103	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.39e-05	0.00103	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.37e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SST—Barrett's esophagus	3.34e-05	0.00101	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CXCL8—Barrett's esophagus	3.32e-05	0.00101	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	3.29e-05	0.000997	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CXCL8—Barrett's esophagus	3.27e-05	0.000991	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.19e-05	0.000968	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.17e-05	0.000959	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SST—Barrett's esophagus	3.14e-05	0.000951	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SLC9A1—Barrett's esophagus	3.11e-05	0.000943	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—APC—Barrett's esophagus	2.82e-05	0.000856	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—APC—Barrett's esophagus	2.66e-05	0.000807	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.65e-05	0.000804	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.63e-05	0.000797	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.57e-05	0.000778	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SST—Barrett's esophagus	2.55e-05	0.000771	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.5e-05	0.000756	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.48e-05	0.000751	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.43e-05	0.000735	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.42e-05	0.000733	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.4e-05	0.000727	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.28e-05	0.000691	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL8—Barrett's esophagus	2.27e-05	0.000687	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL8—Barrett's esophagus	2.25e-05	0.000682	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RELA—Barrett's esophagus	2.21e-05	0.000669	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.2e-05	0.000668	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.13e-05	0.000645	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.09e-05	0.000633	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RELA—Barrett's esophagus	2.08e-05	0.000631	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL8—Barrett's esophagus	2.08e-05	0.00063	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.07e-05	0.000627	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL8—Barrett's esophagus	1.96e-05	0.000594	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.94e-05	0.000589	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.9e-05	0.000575	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.85e-05	0.000561	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.85e-05	0.00056	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APC—Barrett's esophagus	1.82e-05	0.000551	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APC—Barrett's esophagus	1.81e-05	0.000547	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.77e-05	0.000537	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APC—Barrett's esophagus	1.77e-05	0.000536	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.74e-05	0.000529	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.73e-05	0.000524	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.68e-05	0.000509	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APC—Barrett's esophagus	1.66e-05	0.000503	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.58e-05	0.000479	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.53e-05	0.000463	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.5e-05	0.000455	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RELA—Barrett's esophagus	1.42e-05	0.00043	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—Barrett's esophagus	1.42e-05	0.00043	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RELA—Barrett's esophagus	1.41e-05	0.000428	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.39e-05	0.000423	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RELA—Barrett's esophagus	1.38e-05	0.000419	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APC—Barrett's esophagus	1.35e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—Barrett's esophagus	1.34e-05	0.000406	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—Barrett's esophagus	1.33e-05	0.000403	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—Barrett's esophagus	1.3e-05	0.000395	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RELA—Barrett's esophagus	1.3e-05	0.000393	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—Barrett's esophagus	1.28e-05	0.000387	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—Barrett's esophagus	1.22e-05	0.000371	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—Barrett's esophagus	1.2e-05	0.000365	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.18e-05	0.000358	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.14e-05	0.000346	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—Barrett's esophagus	1.12e-05	0.000338	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—Barrett's esophagus	1.05e-05	0.000319	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—Barrett's esophagus	9.92e-06	0.000301	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—Barrett's esophagus	8.66e-06	0.000262	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—Barrett's esophagus	8.45e-06	0.000256	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—Barrett's esophagus	8.22e-06	0.000249	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—Barrett's esophagus	8.16e-06	0.000247	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—Barrett's esophagus	7.99e-06	0.000242	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—Barrett's esophagus	7.96e-06	0.000241	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.9e-06	0.000239	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—Barrett's esophagus	7.51e-06	0.000227	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.81e-06	0.000206	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—Barrett's esophagus	6.65e-06	0.000201	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.26e-06	0.00019	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.21e-06	0.000188	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—Barrett's esophagus	6.09e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.21e-06	0.000158	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.1e-06	0.000124	CbGpPWpGaD
